BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8899121)

  • 1. Cutaneous delayed reaction to ranitidine.
    Gonzalo-Garijo MA; Revenga-Arranz F; Rovira-Farré I
    Allergy; 1996 Sep; 51(9):659-60. PubMed ID: 8899121
    [No Abstract]   [Full Text] [Related]  

  • 2. Maculopapular rash due to delayed-type hypersensitivity from bismuth salts.
    Gratacós Gómez AR; Joyanes Romo JB; Meneses Sotomayor JV; González Jimenez OM; Palacios Cañas A; Gómez Torrijos E
    Contact Dermatitis; 2022 Mar; 86(3):228-229. PubMed ID: 34791673
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute generalized exanthematous pustulosis induced by ranitidine hydrochloride.
    Blanes Martínez M; Silvestre Salvador JF; Vergara Aguilera G; Betlloch Mas I; Pascual Ramírez JC
    Contact Dermatitis; 2003 Jul; 49(1):47. PubMed ID: 14641127
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ranitidine and a rare adverse reaction: urticaria].
    Sancho Calabuig A; Palop Larrea V; López González E; Martínez-Mir I
    Aten Primaria; 1997 Oct; 20(7):396-7. PubMed ID: 9432226
    [No Abstract]   [Full Text] [Related]  

  • 5. Lichenoid eruptions due to the H2-receptor antagonists roxatidine and ranitidine.
    Horiuchi Y; Katagiri T
    J Dermatol; 1996 Jul; 23(7):510-2. PubMed ID: 8772037
    [No Abstract]   [Full Text] [Related]  

  • 6. Generalized exanthematous pustulosis induced by medications.
    Sawhney RA; Dubin DB; Otley CC; Kwan TH; Bowers KE
    Int J Dermatol; 1996 Nov; 35(11):826-7. PubMed ID: 8915744
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed-type hypersensitivity to protamine as a complication of insulin therapy.
    Raap U; Liekenbröcker T; Kapp A; Wedi B
    Contact Dermatitis; 2005 Jul; 53(1):57-8. PubMed ID: 15982236
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ambroxol-induced toxicoderma].
    Saad N; Guillot I; Vautrin C; Freymond N; Catelain A; Kerhoas A; Nicolas JF
    Ann Dermatol Venereol; 2006 Feb; 133(2):181-2. PubMed ID: 16508607
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the skin test reactions in patients with delayed type rash induced by penicillins and cephalosporins.
    Aihara M; Ikezawa Z
    J Dermatol; 1987 Oct; 14(5):440-8. PubMed ID: 2963845
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed-type hypersensitivity reaction to ethambutol and isoniazid.
    Bakkum RS; Waard-Van Der Spek FB; Thio HB
    Contact Dermatitis; 2002 Jun; 46(6):359. PubMed ID: 12190628
    [No Abstract]   [Full Text] [Related]  

  • 11. Repeated patch testing in delayed hypersensitivity to beta-lactam antibiotics.
    Romano A; Di Fonso M; Pietrantonio F; Pocobelli D; Giannarini L; Del Bono A; Fabrizi G; Venuti A
    Contact Dermatitis; 1993 Mar; 28(3):190. PubMed ID: 8462302
    [No Abstract]   [Full Text] [Related]  

  • 12. Dipyridamole-induced eczematous drug eruption with positive patch test reaction.
    Salava A; Alanko K; Hyry H
    Contact Dermatitis; 2012 Aug; 67(2):103-4. PubMed ID: 22775544
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-allergy to ranitidine and nizatidine.
    Morisset M; Moneret-Vautrin DA; Loppinet V; Grandidier S
    Allergy; 2000 Jul; 55(7):682-3. PubMed ID: 10921476
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed hypersensitivity drug reactions diagnosed by patch testing.
    Calkin JM; Maibach HI
    Contact Dermatitis; 1993 Nov; 29(5):223-33. PubMed ID: 8112060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Delayed hypersensitivity to anti-tuberculosis drugs. Proposed practical management plan for exanthema: when to stop, which allergological investigations to perform, and how to restart treatment].
    Ingen-Housz-Oro S; Assier H; Gener G; Milpied B; Soria A; Bernier C; Descamps V; Tetart F; Staumont-Sallé D; Valeyrie-Allanore L; Valois A; Sassolas B; Bensaid B; Lebrun-Vignes B; Barbaud A;
    Ann Dermatol Venereol; 2019 Apr; 146(4):313-318. PubMed ID: 30904277
    [No Abstract]   [Full Text] [Related]  

  • 16. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
    Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
    Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed hypersensitivity to oral nystatin.
    Martínez FV; Muñoz Pamplona MP; García EC; Urzaiz AG
    Contact Dermatitis; 2007 Sep; 57(3):200-1. PubMed ID: 17680880
    [No Abstract]   [Full Text] [Related]  

  • 19. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction.
    Bircher AJ; Flückiger R; Buchner SA
    Br J Dermatol; 1990 Oct; 123(4):507-14. PubMed ID: 2151304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
    Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.